Literature DB >> 10758237

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.

C Devito1, M Levi, K Broliden, J Hinkula.   

Abstract

An HIV-1 p24 capture enzyme linked immunosorbent assay (ELISA) was developed and used in a study of B-cell epitopes in rabbits immunised with different gag p24 antigens. Rabbits were immunised with virion HIV-1/Lai, baculovirus recombinant p24, Escherichia coli recombinant p24-15 and a mixture of synthetic peptides representing sequences of HIV-1 gag p24 protein, respectively. Five out of nine rabbits developed antibodies that could be used for an antigen capture ELISA. No significant differences in IgG titers to the whole gag protein were seen when comparing rabbits immunised with four different antigens. Three major common linear epitope regions were mapped in the rabbits immunised with virion HIV-1/Lai and baculovirus recombinant p24. The rabbit immunised with HIV-1 gag peptides had the broadest linear epitope reactive responses whereas animals immunised with E. coli recombinant antigen had the most restricted linear epitope response. The capture ELISA method thus developed using the different rabbit anti-p24 IgG preparations was shown to capture isolates from HIV-1 subtypes or clades A to G. Only rabbits immunised with virion HIV-1/Lai and baculovirus recombinant p24 developed IgG that was capable of efficiently capturing HIV-1 p24 in ELISA, indicating the importance of preparing antibodies able to recognise native or discontinuous and linear antigen configurations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758237     DOI: 10.1016/s0022-1759(00)00141-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.

Authors:  Maria E Cardona; Jorma Hinkula; Kristin Gustafsson; Birger Christensson; Britta Wahren; Abdalla J Mohamed; C I Edvard Smith; H Jose Arteaga
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

2.  GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.

Authors:  Alenka Jejcic; Stefan Höglund; Anders Vahlne
Journal:  Retrovirology       Date:  2010-03-15       Impact factor: 4.602

3.  Small molecule targets Env for endoplasmic reticulum-associated protein degradation and inhibits human immunodeficiency virus type 1 propagation.

Authors:  Alenka Jejcic; Robert Daniels; Laura Goobar-Larsson; Daniel N Hebert; Anders Vahlne
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

4.  Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro.

Authors:  Claudia Devito; Rada Ellegård; Tina Falkeborn; Lennart Svensson; Mats Ohlin; Marie Larsson; Kristina Broliden; Jorma Hinkula
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

5.  Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.

Authors:  Lech Ignatowicz; Jolanta Mazurek; Chaniya Leepiyasakulchai; Markus Sköld; Jorma Hinkula; Gunilla Källenius; Andrzej Pawlowski
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

6.  A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.

Authors:  Chien-Hsing Chang; Jorma Hinkula; Meiyu Loo; Tina Falkeborn; Rongxiu Li; Thomas M Cardillo; Edmund A Rossi; David M Goldenberg; Britta Wahren
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

7.  Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.

Authors:  Si Min Zhang; Alenka Jejcic; James P Tam; Anders Vahlne
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

8.  DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.

Authors:  Sanna Nyström; Andreas Bråve; Tina Falkeborn; Claudia Devito; Björn Rissiek; Daniel X Johansson; Ulf Schröder; Satoshi Uematsu; Shizuo Akira; Jorma Hinkula; Steven E Applequist
Journal:  Vaccines (Basel)       Date:  2013-09-25

9.  Multiple nuclear-replicating viruses require the stress-induced protein ZC3H11A for efficient growth.

Authors:  Shady Younis; Wael Kamel; Tina Falkeborn; Hao Wang; Di Yu; Robert Daniels; Magnus Essand; Jorma Hinkula; Göran Akusjärvi; Leif Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.